Arcadia Biosciences, Inc. Stock News
$4.10
4.59%
yesterday
Nasdaq,
Oct 24, 10:00 pm CET
Arcadia Biosciences, Inc. Stock News
Neutral
GlobeNewsWire
●
2 months ago
-- Arcadia revenues increase 11% year over year driven by 24% growth in Zola ® -- -- Arcadia receives 2.7 million shares of stock in ABVE --
Neutral
Seeking Alpha
●
6 months ago
Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q1 2025 Earnings Conference Call May 8, 2025 2:00 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President and Chief Executive Officer Conference Call Participants Ben Klee - Lake Street Operator Hello, and welcome to Arcadia Biosciences First Quarter 2025 Financial Results and Business Highlights Conference Call.
Neutral
GlobeNewsWire
●
6 months ago
-- Revenues increase 22% year over year driven by 90% growth in Zola ® -- -- Arcadia sells patents for $750K and eliminates $1M in liabilities -- -- Roosevelt agreement amended to provide greater certainty regarding exchange ratio -- DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness product...
Neutral
GlobeNewsWire
●
6 months ago
Arcadia Biosciences, Inc.® (Nasdaq: RKDA) will release its financial and business results for the first quarter of 2025 on May 8, 2025 at 2:00 p.m. ET.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
